α-Cyano-4-hydroxycinnamic acid butylamine salt (CAS 355011-53-9)

α-Cyano-4-hydroxycinnamic acid butylamine salt (ACHCB) has emerged as a compound of great interest to scientists and researchers, owing to its promising potential in various research and laboratory experiments. Derived from cinnamic acid, a naturally occurring phenolic compound abundantly found in plants, α-Cyano-4-hydroxycinnamic acid butylamine salt exhibits notable characteristics. It presents itself as a white crystalline solid with a melting point of approximately 110°C and demonstrates solubility in water and ethanol. Its diverse applications in scientific research encompass organic synthesis, drug design, biochemistry, protein structure-function analysis, and catalysis in organic reactions. Moreover, α-Cyano-4-hydroxycinnamic acid butylamine salt has found utility in investigating drug pharmacokinetics, as well as in the structural analysis of DNA and RNA. One intriguing aspect of α-Cyano-4-hydroxycinnamic acid butylamine salt is its proposed role as an inhibitor of specific enzymes, notably cyclooxygenase-2 (COX-2). By inhibiting COX-2, this compound effectively reduces the production of prostaglandins and other pro-inflammatory mediators. Consequently, it holds potential therapeutic benefits in the treatment of inflammation and pain. Additionally, α-Cyano-4-hydroxycinnamic acid butylamine salt has demonstrated inhibitory effects on other enzymes such as lipoxygenases, further showcasing its wide-ranging positive impacts.